No CrossRef data available.
Article contents
Evaluation of an antigen-test–based strategy to reduce duration of transmission-based precautions for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in hospitalized patients
Published online by Cambridge University Press: 04 August 2023
Abstract
An academic hospital implemented a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antigen-test–based strategy to facilitate discontinuation of precautions for patients admitted with a positive SARS-CoV-2 test. Of 171 patients that underwent antigen testing, 68% had an initial negative test performed a median of 5 days after admission. Antigen testing reduced isolation time by 144 hours.
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic. Centers for Disease Control and Prevention website. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html. Published 2022. Accessed January 12, 2023.Google Scholar
O’Reilly, GM, Mitchell, RD, Mitra, B, et al. Impact of patient isolation on emergency department length of stay: a retrospective cohort study using the Registry for Emergency Care. Emerg Med Australas 2020;32:1034–1039.CrossRefGoogle ScholarPubMed
Talbot, TR, Hayden, MK, Yokoe, DS, et al. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: challenges and considerations. Infect Control Hosp Epidemiol 2023;44:2–7.CrossRefGoogle ScholarPubMed
Alsuhaibani, MA, Kobayashi, T, Trannel, A, et al. Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020. Infect Control Hosp Epidemiol 2022;43:974–978.CrossRefGoogle ScholarPubMed
Korenkov, M, Poopalasingam, N, Madler, M, et al. Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals. J Clin Microbiol 2021;59:e0089621.CrossRefGoogle ScholarPubMed
Puhach, O, Meyer, B, Eckerle, I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2023;21:147–161.Google ScholarPubMed
Kirby, JE, Riedel, S, Dutta, S, et al. SARS-CoV-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort. Clin Microbiol Infect 2023;29:94–100.CrossRefGoogle ScholarPubMed
In vitro diagnostics EUAs—antigen diagnostic tests for SARS-CoV-2. US Food and Drug Administration website. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2#SerialTesting. Published 2022. Accessed February 1, 2023.Google Scholar